Food and Drug Administration Unable to Regulate CBD Products Under Its Current Structure
The U.S. Food and Drug Administration (FDA) treats products containing CBD or cannabis-derived compounds as it does any other FDA-regulated products — meaning they are subject to the same authorities and requirements as any other substance. This guidance was issued near the end of January 2023, whereby the FDA said it is unable to regulate […]